Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2006-09-30
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Specific Aim #1 is to determine if there is a difference in depressive symptoms between women with breast cancer assigned to one of two treatment conditions: moderated online support or peer-led online support.
• H1: Women with breast cancer who participate in moderated online support will report fewer depressive symptoms than women with breast cancer in peer led online support.
2. Specific Aim #2 is to determine if there is a difference in perceived social support between women with breast cancer who are assigned to one of two treatment conditions: moderated online support or peer-led online support.
• H2: Women with breast cancer who participate in moderated online support will report greater perceived social support than women with breast cancer in peer-led online support.
3. Specific Aim #3 is to determine if there is a difference in quality of life in women with breast cancer who are assigned to one of two treatment conditions: moderated online support or peer-led online support.
* H3: Women with breast cancer who participate in moderated online support will report better quality of life than women with breast cancer in peer-led online support.
NOTE: Once the study began, it was obvious that we could not prevent anyone from joining a support group, if that was her choice. We also could not control if participants joined a second online support group or face-to-face group during the study. Therefore, we decided to omit a "usual care" (no support) group. The study was completed with just two groups: moderated and peer-support.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
NOTE: It was obvious that we could not prevent anyone from joining a support group, if that was her choice. We also could not control if participants joined a second online support group or face-to-face group during the study. Therefore, we dropped the "usual care" (no support) group. The study was completed with just two groups: moderated and peer-support.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
moderated online support
12-week online support led by a healthcare professional
moderated support
one 12-week online support group led by a professional healthcare provider
peer-led support
12-week online support group in a peer-led format
peer-led
12-week online support in a peer-led format
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
moderated support
one 12-week online support group led by a professional healthcare provider
peer-led
12-week online support in a peer-led format
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 21 years of age
* Internet access; Able to read and write English
* Have completed treatment for breast cancer in the past 36 months or are receiving treatment
* Do not currently belong to an online or face-to-face cancer support group
* Internet access
Exclusion Criteria
* not diagnosed with breast cancer
* under 21 years of age
* received treatment more than 36 months ago for breast cancer
* no Internet access
* unable to read and write English
21 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Christiana Care Health Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Delaware School of Nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paula Klemm, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Delaware School of Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Delaware
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DDD#504604
Identifier Type: -
Identifier Source: org_study_id